CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can masks and air purifiers shield COPD patients from wildfire smoke?
Disease control OngoingThis pilot study tests whether giving N95 masks and indoor air cleaners to 20 older adults with COPD can reduce lung flare-ups during poor air quality from wildfires. Participants are Kaiser Permanente members aged 65+ who use oxygen. The study focuses on whether this approach is…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug aims to cut COPD attacks in heavy smokers
Disease control OngoingThis study tests an experimental drug called astegolimab against a placebo in 1290 people with COPD who have frequent flare-ups. Participants are current or former smokers. The main goal is to see if the drug reduces the number of moderate to severe COPD attacks over one year.
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New inhaler aims to help COPD patients breathe easier
Disease control OngoingThis study tests an experimental inhaler called HSK39004 in 180 adults with COPD, a long-term lung disease that makes breathing hard. Participants will use the inhaler or a placebo for 4 weeks to see if it safely improves lung function. The goal is to control the disease and ease…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for COPD sufferers: drug targets high eosinophils to cut Flare-Ups
Disease control OngoingThis study tests a drug called tozorakimab in people with chronic obstructive pulmonary disease (COPD) who have a history of flare-ups and high levels of eosinophils (a type of white blood cell). The trial involves 98 participants who receive either tozorakimab or a placebo every…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New shot aims to cut dangerous COPD attacks in high-risk patients
Disease control OngoingThis study tests an investigational drug called tozorakimab in about 1,454 adults with symptomatic COPD who have had at least two moderate or one severe flare-up in the past year. Participants continue their usual inhaled medications and receive either tozorakimab or a placebo as…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Your Phone's microphone could soon screen for lung disease
Diagnosis OngoingThis study is testing whether an artificial intelligence program can detect chronic obstructive pulmonary disease (COPD) by analyzing cough sounds recorded on a smartphone. Researchers will collect cough recordings and medical data from 3,000 adults in China, both with and withou…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Sir Run Run Shaw Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Mindfulness may ease stress and anxiety in COPD patients, small study suggests
Symptom relief OngoingThis pilot study tests whether an 8-week mindfulness program (MBSR) can reduce anxiety, depression, and stress in people with COPD who are already in pulmonary rehab. About 44 participants will be followed for 12 months. The goal is to see if this mind-body approach improves emot…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Université Libre de Bruxelles • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New sonic device aims to make lung mucus clearance easier
Symptom relief OngoingThis study tests a new device called SonoHeal that uses sound waves to help people with cystic fibrosis, bronchiectasis, or COPD clear mucus from their lungs. Fifteen participants will try the device at home to see if it is easy to use and acceptable. The study also compares it t…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Cognita Labs LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Shock therapy for lungs? electrical zaps may boost exercise in COPD
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether using a device that sends mild electrical pulses to the leg muscles can help people with COPD feel more confident about exercise, reduce shortness of breath during activity, and lessen fatigue. Forty patients with mild to severe COPD will receive the stim…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Phase: NA • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Russian COPD study seeks to understand frequent lung attacks
Knowledge-focused OngoingThis study looks at over 1,700 people in Russia who have moderate to severe COPD and often have flare-ups. Researchers will collect information on their health, lifestyle, and treatments to better understand the disease. The goal is to learn more about these patients to help impr…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can your blood vessels predict lung trouble?
Knowledge-focused OngoingThis study explores how problems with blood vessel function and genetics may contribute to early-stage COPD and emphysema. Researchers followed over 4,300 adults from a larger heart study, measuring lung function and CT scans. The goal is to understand risk factors, not to test a…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Skin sensor could alert doctors to rising pain in cancer and COPD patients
Knowledge-focused OngoingThis study tests whether a wearable skin sensor can tell the difference between mild, moderate, and severe pain in 37 adults with cancer or COPD. Participants wear the device for up to a week and report their pain levels. The goal is to create an algorithm that alerts caregivers …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
COPD study probes the power of mental imagery
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether people with COPD can imagine movements as clearly as those without the disease. Researchers will compare 188 participants using questionnaires and timing tests. The goal is to better understand how COPD might affect the brain's ability to picture and f…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Kutahya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:13 UTC
-
COPD patients' hidden bladder troubles under the microscope
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find out how common lower urinary tract symptoms (like leaking or trouble emptying the bladder) are in people with COPD, and how much they know about pelvic floor health. Researchers will ask 30 participants to fill out questionnaires about their breathing, bla…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sponsor: Kutahya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:40 UTC